Investment Managers Series Trust II AXS Real Estate Income ETF RINC 深沪

已收盘 09-18 16:00:00 美东时间

22.2013

0.000

0.00%

华盛通

立即下载

最高--
今开--
成交量 0股
最低 --
昨收 22.2013
总市值 3419.00万
52周最高 22.74
市盈率 ^静 --
换手率 0.00%
52周最低 17.06
委比 0.00%
总股本 154.00万
历史最高 22.7683
量比 0
振幅 0.00%
历史最低 16.63
每手 1
风险率 0.00%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

PDS Biotech Reports Third Quarter 2026 Financial Results

PDS Biotech reported Q3 2026 updates, completing a $22.3M PIPE financing led by Nant Capital and appointing new board members. The company highlighted clinical progress for its lead program PDS0301 and secured new patents. Financially, cash reserves stood at $15.2M, with a net loss of $7.6M, down from $9.0M in Q3 2025. R&D expenses decreased by $2.5M, while G&A costs rose slightly.

11-13 13:00
UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights

UroGen Pharma reported Q3 2026 revenue of $68.0 million for ZUSDURI, up 35% QoQ, and $21.0 million for JELMYTO. FDA accepted UGN-103 NDA with PDUFA date set for June 14, 2027. UGN-501 Phase 1 trial began with first patient dosed. Total revenue reached $89.0 million, up from $27.5 million in Q3 2025. R&D expenses rose to $26.0 million, SG&A to $47.2 million. Net loss was $1.5 million, or $0.03 per share. UroGen updated 2026 JELMYTO revenue guidanc...

11-04 13:00
ANI Pharmaceuticals to Present at Upcoming November Investor Conferences

ANI Pharmaceuticals announced that CEO Nikhil Lalwani and executives will participate in two upcoming investor conferences: the Guggenheim 3rd Annual Healthcare Innovation Conference on November 10, 2026, at 1:30 p.m. ET, and the 2026 Jefferies Global Healthcare Conference in London on November 17, 2026, at 9:30 a.m. GMT. Live and archived webcasts will be available on the company’s website. ANI is a biopharmaceutical company focused on rare dise...

11-03 11:55
MISTRAS Group, Inc. Announces Expiration of “Go-Shop” Period

MISTRAS Group, Inc. announced the expiration of the 40-day "go-shop" period under its merger agreement with H.I.G. Capital, with no alternative acquisition proposals received. During this period, the company actively solicited inquiries from 122 third parties, including 40 with whom confidentiality agreements were signed. The all-cash transaction, valued at $20.35 per share, represents an 8% and 13% premium over the company's 30- and 90-day unaff...

10-28 20:51
UroGen’s Final Results from Olympus Five-Year Follow-Up Study Reinforces Durable Response with JELMYTO in Patients with Low-Grade Upper Tract Urothelial Cancer

UroGen Pharma announced the publication of five-year follow-up data from the Olympus study in *Therapeutic Advances in Urology*, highlighting JELMYTO's long-term efficacy in treating low-grade upper tract urothelial cancer (LG-UTUC). Among 41 patients achieving complete response, the median duration of response was 47.8 months, with no progression to high-grade disease observed. The findings support JELMYTO as a durable, kidney-sparing treatment ...

10-28 12:00
ONEOK Announces Higher Third-Quarter 2026 Earnings and Increases 2026 Financial Guidance

ONEOK, Inc. reported higher third-quarter 2026 results, with net income of $1.38 billion and adjusted EBITDA of $2.24 billion, up 6% year-over-year. The company highlighted strong performance across its segments, including a 6% increase in NGL raw feed throughput volumes and a 4% rise in Permian region natural gas volumes processed. ONEOK also announced an increase in its 2026 financial guidance, reflecting strong year-to-date performance and con...

10-27 20:15
Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research

Niki BioSolutions subsidiary DiamiR Biosciences has signed an agreement with Charter Research to perform APOE genotyping for Alzheimer’s disease trials. APOE status is critical for determining eligibility, safety monitoring, and risk stratification in Alzheimer’s research. The collaboration leverages Niki’s CAP-accredited and CLEP-approved testing platform, enhancing Charter Research’s ability to meet modern clinical trial requirements. This part...

10-23 12:00
Clearway Energy, Inc. to Report Third Quarter 2026 Financial Results on November 9, 2026

Clearway Energy, Inc. will release its Third Quarter 2026 financial results on November 9, 2026, followed by a conference call and webcast at 5:00 p.m. Eastern. The webcast, including presentation materials, will be available on the Company’s website and archived for later access. Clearway Energy is one of the largest owners of clean energy generation assets in the U.S., with approximately 13.9 GW of gross capacity. For more information, contact ...

10-20 11:00
Integra Announces Completion of Refinancing Transactions

Integra LifeSciences Holdings Corporation announced the completion of a $450 million private offering of 9.500% senior secured notes due 2033 and the amendment of its $1.65 billion credit facility. The funds will be used to refinance existing debt and cover related expenses. The notes are senior secured obligations and were offered to qualified institutional buyers and certain non-U.S. investors under specific regulations. This press release is n...

10-19 20:05
ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules

ANI Pharmaceuticals launched Duloxetine Delayed-Release Capsules 20, 30, and 60 mg, a generic version of Cymbalta. The company aims to provide stable supply in a limited-player market through partnerships and regulatory efforts. U.S. annual sales for the product were approximately $247 million in 2026. ANI is a biopharmaceutical company focused on rare disease, generics, and brands businesses.

10-19 10:55

年度	派息内容	派息日期
	0.16	2025-08-28
	0.16	2025-08-31
	0.16	2025-06-27
	0.16	2025-05-29
	0.16	2025-04-28
	0.18	2025-03-28
	0.18	2025-02-27
	0.18	2025-01-30
	0.18	2024-12-30
	0.20	2024-11-29
	0.20	2024-10-30
	0.20	2024-09-30
	0.20	2024-08-30
	0.20	2024-07-31
	0.20	2024-06-28
	0.20	2024-05-30
	0.20	2024-04-29
	0.20	2024-03-28
	0.20	2024-02-28
	0.20	2024-01-31
	0.20	2023-12-29
	0.20	2023-11-30
	0.20	2023-10-30
	0.20	2023-09-29
	0.20	2023-08-31
	0.17	2023-07-31
	0.17	2023-06-30
	0.17	2023-05-30
	0.17	2023-04-28
	0.17	2023-03-30
	0.17	2023-02-27
	0.17	2023-01-30
	0.17	2022-12-30
	0.17	2022-11-30
	0.17	2022-10-31
	0.17	2022-09-30
	0.17	2022-08-31
	0.17	2022-07-29
	0.17	2022-06-30
	0.17	2022-05-31
	0.17	2022-04-29
	0.17	2022-03-31
	0.17	2022-02-25
	0.17	2022-01-28
	0.17	2021-12-31
	0.17	2021-11-30
	0.17	2021-10-29
	0.17	2021-09-30
	0.17	2021-08-31
	0.17	2021-07-30
	0.17	2021-06-30
	0.17	2021-05-28
	0.18	2021-04-30
	0.19	2021-03-31
	0.19	2021-02-26
	0.20	2021-01-29
	0.20	2020-12-31
	0.20	2020-11-30
	0.20	2020-10-30
	0.20	2020-09-30
	0.20	2020-08-31
	0.20	2020-07-31
	0.20	2020-06-30
	0.20	2020-05-29
	0.20	2020-04-30
	0.20	2020-03-31
	0.20	2020-02-28
	0.20	2020-01-31
	0.20	2019-12-31
	0.20	2019-11-27
	0.20	2019-10-31
	0.20	2019-09-30
	0.20	2019-08-30
	0.21	2019-07-31
	0.21	2019-06-28
	0.21	2019-05-31
	0.22	2019-04-30
	0.22	2019-03-29
	0.22	2019-02-28
	0.21	2019-01-31
	0.21	2018-12-31
	0.23	2018-11-30
	0.22	2018-10-31
	0.22	2018-09-28
	0.24	2018-08-31
	0.22	2018-07-31
	0.24	2018-06-29
	0.22	2018-05-31
	0.22	2018-04-30
	0.23	2018-03-29
	0.24	2018-02-28
	0.19	2018-01-31
	0.26	2017-12-29
	0.23	2017-11-30
	0.22	2017-10-31
	0.23	2017-09-29
	0.21	2017-08-31
	0.21	2017-07-31
	0.21	2017-06-30
	0.21	2017-05-31
	0.21	2017-04-28
	0.22	2017-03-31
	0.21	2017-02-28
	0.18	2017-01-31
	0.25	2016-12-30
	0.22	2016-11-30
	0.21	2016-10-31
	0.22	2016-09-30
	0.21	2016-08-31
	0.22	2016-07-29
	0.14	2016-06-30
	0.14	2016-05-31
	0.14	2016-04-29
	0.19	2016-03-31
	0.21	2016-02-29
	0.20	2016-01-29
	0.38	2015-12-31
	0.31	2015-11-30
	0.29	2015-10-30
	0.32	2015-09-30
	0.32	2015-08-31
	0.30	2015-07-30
	0.33	2015-06-30
	0.21	2015-05-29
	0.29	2015-04-30
	0.30	2015-03-31
	0.28	2015-02-27
	0.21	2015-01-30
	0.65	2014-12-31
	0.34	2014-11-28
	0.34	2014-10-31
	0.21	2014-09-30
	0.35	2014-08-29
	0.37	2014-07-31
	0.34	2014-06-30
	0.31	2014-05-30
	0.31	2014-04-30
	0.31	2014-03-31
	0.30	2014-02-28
	0.24	2014-01-31
	0.56	2013-12-31
	0.31	2013-11-29
	0.32	2013-10-31
	0.27	2013-09-30
	0.35	2013-08-30
	0.37	2013-07-31
	0.31	2013-06-28
	0.34	2013-05-31
	0.35	2013-04-30
	0.32	2013-03-28
	0.32	2013-02-28
	0.28	2013-01-31
	0.43	2012-12-31
	0.32	2012-11-30
	0.34	2012-10-31
	0.35	2012-09-28
	0.37	2012-06-29
	0.37	2012-05-31
	0.37	2012-04-30
	0.35	2012-03-30
	0.31	2012-02-29
	0.24	2012-01-31
	0.92	2011-12-30
	0.33	2011-11-30
	0.29	2011-10-31
	0.30	2011-09-30
	0.28	2011-08-31
	0.32	2011-07-29
	0.28	2011-06-30
	0.33	2011-05-31
	0.29	2011-04-29
	0.34	2011-03-31
	0.29	2011-02-28
	0.20	2011-01-31
	0.23	2010-12-31

公司名称	High Yield ETF
行业分类	Investment Trusts/Mutual Funds
业务描述	Functions as an exchange traded fund

Investment Managers Series Trust II AXS Real Estate Income ETF RINC 深 沪

22.2013

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Investment Managers Series Trust II AXS Real Estate Income ETF RINC 深沪